Anti-EPHA8/ EEK/ EK3 monoclonal antibody

Anti-EPHA8/ EEK/ EK3 antibody for FACS & in-vivo assay

Target products collectionGo to EPHA8/EPHA8 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T58266-Ab-1/ GM-Tg-hg-T58266-Ab-2Anti-Human EPHA8 monoclonal antibodyHuman
GM-Tg-rg-T58266-Ab-1/ GM-Tg-rg-T58266-Ab-2Anti-Rat EPHA8 monoclonal antibodyRat
GM-Tg-mg-T58266-Ab-1/ GM-Tg-mg-T58266-Ab-2Anti-Mouse EPHA8 monoclonal antibodyMouse
GM-Tg-cynog-T58266-Ab-1/ GM-Tg-cynog-T58266-Ab-2Anti-Cynomolgus/ Rhesus macaque EPHA8 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T58266-Ab-1/ GM-Tg-felg-T58266-Ab-2Anti-Feline EPHA8 monoclonal antibodyFeline
GM-Tg-cang-T58266-Ab-1/ GM-Tg-cang-T58266-Ab-2Anti-Canine EPHA8 monoclonal antibodyCanine
GM-Tg-bovg-T58266-Ab-1/ GM-Tg-bovg-T58266-Ab-2Anti-Bovine EPHA8 monoclonal antibodyBovine
GM-Tg-equg-T58266-Ab-1/ GM-Tg-equg-T58266-Ab-2Anti-Equine EPHA8 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T58266-Ab-1/ GM-Tg-hg-T58266-Ab-2; GM-Tg-rg-T58266-Ab-1/ GM-Tg-rg-T58266-Ab-2;
GM-Tg-mg-T58266-Ab-1/ GM-Tg-mg-T58266-Ab-2; GM-Tg-cynog-T58266-Ab-1/ GM-Tg-cynog-T58266-Ab-2;
GM-Tg-felg-T58266-Ab-1/ GM-Tg-felg-T58266-Ab-2; GM-Tg-cang-T58266-Ab-1/ GM-Tg-cang-T58266-Ab-2;
GM-Tg-bovg-T58266-Ab-1/ GM-Tg-bovg-T58266-Ab-2; GM-Tg-equg-T58266-Ab-1/ GM-Tg-equg-T58266-Ab-2
Products NameAnti-EPHA8 monoclonal antibody
Formatmab
Target NameEPHA8
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody, Therapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-EPHA8 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species EPHA8/ EEK/ EK3 VLP (virus-like particle) (Products Developing)


    Target information

    Target IDGM-T58266
    Target NameEPHA8
    Gene ID2046,13842,60589,708378,487383,101095669,517368,100071673
    Gene Symbol and SynonymsEEK,EK3,EPHA8,HEK3,mKIAA1459
    Uniprot AccessionP29322,P29321
    Uniprot Entry NameEPHA8_HUMAN,EPHA8_RAT
    Protein Sub-locationTransmembrane Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000070886
    Target ClassificationKinase

    The target: EPHA8, gene name: EPHA8, also named as EEK, EK3, HEK3. This gene encodes a member of the ephrin receptor subfamily of the protein-tyrosine kinase family. EPH and EPH-related receptors have been implicated in mediating developmental events, particularly in the nervous system. Receptors in the EPH subfamily typically have a single kinase domain and an extracellular region containing a Cys-rich domain and 2 fibronectin type III repeats. The ephrin receptors are divided into 2 groups based on the similarity of their extracellular domain sequences and their affinities for binding ephrin-A and ephrin-B ligands. The protein encoded by this gene functions as a receptor for ephrin A2, A3 and A5 and plays a role in short-range contact-mediated axonal guidance during development of the mammalian nervous system. [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.